FDA chief stands by vaccine approval criteria despite …
FDA chief stands by vaccine approval criteria despite Trump pressure … The head of the US Food and Drug Administration has risked sparking a fresh conflict with Donald Trump over the timing of a …
5 FDA approval decisions to watch in the 4th quarter …
In guidelines released this summer, the FDA has said it will require a vaccine be at least 50% effective in preventing COVID-19 before it grants an approval.On safety, the agency wants to see data from thousands of study participants followed for at least six months after vaccination. The FDA could also first grant an emergency use authorization, or EUA, which typically requires less data.
FDA chief stands by vaccine approval criteria despite …
The head of the US Food and Drug Administration has risked sparking a fresh conflict with Donald Trump over the timing of a coronavirus vaccine, after insisting his scientists would stick to a set of guidelines that the US president has threatened to overrule. Stephen Hahn, FDA commissioner, said on Tuesday his officials would assess …
Subscribe to the FT to read: Financial Times FDA chief …
The US presidential debate: five things to watch out for; Vatican-gate: more London luxury property deals revealed; Joe Biden portrays Donald Trump as tax dodger after new revelations
Moderna trial investigator worries about political …
Dr. Scott Gottlieb, the former FDA commissioner under Trump, told CNBC on Wednesday the American public would find out if there was political interference in the approval of a vaccine.
Early vaccine approval is biggest test yet for FDA chief …
Dr Hahn said Mr Trump has not once tried to put pressure on him to approve a vaccine before the election. The question some are asking is what he would do if the president did.
FDA and CDC walk back statements citing political pressure …
Then, on Saturday, Trump fired off a Twitter blast aimed at the “deep state, or whoever, over at the FDA.” Pressure from Health Secretary Azar also ratcheted up ahead of the FDA’s Sunday …
Roche’s $1.5B Tamiflu stockpiling lawsuit drags on as U.S …
Roche has failed to squash a $1.5 billion False Claims Act suit centered on Tamiflu stockpiling for a flu pandemic. A Maryland federal judge on Monday denied Roche’s motion to dismiss the …
FDA head needs to tell Trump the agency is not part of …
With Trump’s reelection chances circling the drain, this decision is getting people worried that even greater pressure will be exerted for a vaccine approval pre-election.
Experts fear political pressure on COVID-19 vaccine | TheHill
Public health experts are raising red flags that the Trump administration could exert political pressure on the Food and Drug Administration (FDA) to approve a COVID-19 vaccine before one is ready.